Current status of islet transplantation;Estado actual del trasplante de islotes pancreáticos

Cirugia Espanola

Volumn 81, Issue 4, 2007, Pages 177-191

  Balibrea del Castillo, José María ^a,b   Vara Ameigeiras, Elena ^a   Arias Díaz, Javier ^a   García Martín, M Cruz ^a   García Pérez, Juan Carlos ^a   Balibrea Cantero, José Luis ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b NONE   (Spain)

Author keywords

Autotransplantation; Diabetes; Immunosupression; Islet transplantation; Living donor; Non heart beating donor

Indexed keywords

EID: 34248584753     PISSN: 0009739X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-739X(07)71297-6     Document Type: Article

References (127)

1. Arias-Díaz J, Calleja J, Vara E, García C, Torres-Melero J, Garcia-Sabrido JL, et al. Delayed islet autotransplantation after total pancreatectomy. Transplant Proc. 1994;26:3521-2.
2. ADA statement for pancreas transplantation. Diabetes Care. 2004; 27 Suppl: 105.
3. Ryan EA, Bigam D, Shapiro AM. Current indications for pancreas or islet transplant. Diabetes Obes Metab. 2006;8:1-7.
4. Robertson RP. Islet transplantation as a treatment for diabetes-A work in progress. N Engl J Med. 2004;350:694-705.
5. Luzi L, Perseghin G, Brendel MD. Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients. Diabetes. 2001;50:277-82.
6. Puzi L, Perseghin G, Brendel M, Terruzzi I, Battezzati A, Eckhard M, et al. Metabolic effects of restoring partial beta cell function after islet allotransplantation in type 1 diabetic patients. Diabetes. 2001;50:277-82.
7. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free inmunosupressive regimen. N Engl J Med. 2000;343:230-8.
8. Warnock GL, Meloche RM, Thompson D. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus. Arch Surg. 2005; 140:735-44.
9. Ryan EA, Lakey JR, Paty BW. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes. 2002;51:2148-57.
10. Frutos MA, Ruiz P, Mansilla JJ. Pancreas donation for islet transplantation. Transplant Proc 2005;37:1560-1.
11. González Molina M, Alonso A, Briones R, Fernández N, Caballero A, Miranda JM, et al. Pancreas islet transplantation in patients with type 1 diabetes mellitus after kidney transplantation. Transplant Proc. 2005;37:1443-5.
12. Conget I, Piquer S, Julia M, Gomis R, Esmatjes E, Garcia-Pagan JC, et al. Feasibility and safety of pancreatic islet transplantation in the liver by portal vein catheterization using the transjugular route. Transplantation. 2006;81:1220-1.
13. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54:2060-9.
14. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant. 2005;5: 2037-26.
15. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, et al. Internacional trial of the Edmonton Protocol for islet transplantation. N Engl J Med. 2006;355:1318-30.
16. Matesanz R. La necesaria coordinación del trasplante de páncreas, islotes y riñón en Españia. Cir Esp. 2005;77:187-93.
17. Kandaswamy R, Sutherland DE. Pancreas versus islet transplantation in diabetes mellitus: How to allocate deceased donor pancreata? Transplant Proc. 2006;38:365-7.
18. Lee TC, Barshes NR, O'Mahony CA, Nguyen L, Brunicardi FC, Ricordi C, et al. The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy. Transplant Proc. 2005;37:2263-5.
19. Hu YF, Chong RL, Shao AH, Ye RS, Gu ZF, Zhang HD, et al. The influences of islet transplantation on metabolic abnormalities and diabetic complications. Horm Metab Res. 1989;21:198-202.
20. Fiorina P, Gremizzi C, Maffi P, Caldara R, Tavano D, Monti L, et al. Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients. Diabetes Care. 2005;28:1358-65.
21. Fiorina P, Folli F, Bertuzzi F, Maffi P, Finzi G, Venturini M, et al. Long-term beneficial effect of islet transplantation on diabetic macro-/ microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care. 2003;26:1129-36.
22. Clayton HA, Swift SM, Turner JM, James RF, Bell PR. Non-heart-beating organ donors: a potential source of islets for transplantation? Transplantation. 2000;69:2094-8.
23. Markmann JF, Deng S, Desai NM. The use of non-heart-baeting donors for isolated pancreatic islet transplantation. Transplantation. 2003;75:1423-9.
24. Matsumoto S, Tanaka K. Pancreatic islet cell transplantation using non-heart-beating donors (NHBDs). J Hepatobiliary Pancreat Surg. 2005; 12:227-30.
25. Matsumoto S, Tanaka K, Strong DM, Reems JA. Efficacy of human islet isolation from the tail section of the pancreas for the possibility of living donor islet transplantation. Transplantation. 2004; 78:839-43.
26. Slingsby BT, Akabayashi A. Live organ-donation for islet transplantation. Lancet. 2005;366:26-7.
27. Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Nagata H, Yonekawa Y, et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet. 2005;365:1642-4.
28. Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Nagata H, Yonekawa Y, et al. Insulin independence of unstable diabetic patient after single living donor islet transplantation. Transplant Proc. 2005;37: 3427-9.
29. Helling TS. Surgical management of chronic pancreatitis and the role of islet cell autotransplantation. Curr Surg. 2003;60:463-9.
30. Ahmad SA, Lowy AM, Wray CJ, D'Alessio D, Choe KA, James LE, et al. Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis. J Am Coll Surg. 2005;201:680-7.
31. Rodriguez Rilo HL, Ahmad SA, D'Alessio D, Iwanaga Y, Kim J, Choe KA, et al. Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis. J Gastrointest Surg. 2003;7:978-89.
32. Clayton HA, Davies JE, Pollard CA, White SA, Musto PP, Dennison AR. Pancreatectomy with islet autotransplantation for the treatment of severe chronic pancreatitis: the first 40 patients at the Leicester general hospital. Transplantation. 2003;76:92-8.
33. Lee BW, Jee JH, Heo JS, Choi SH, Jang KT, Noh JH, et al. The favorable outcome of human islet transplantation in Korea: experiences of 10 autologous transplantations. Transplantation. 2005;79: 1568-74.
34. Berney T, Mathe Z, Bucher P Demuylder-Mischler S, Andres A, Bosco D, et al. Islet autotransplantation for the prevention of surgical diabetes after extended pancreatectomy for the resection of benign tumors of the pancreas. Transplant Proc. 2004;36:1 123-4.
35. Alsaif F, Molinari M, Al-Masloom A, Lakey JR, Kin T, Shapiro AM. Pancreatic islet autotransplantation with completion pancreatectomy in the management of uncontrolled pancreatic fistula after whipple resection for ampullary adenocarcinoma. Pancreas. 2006; 32:430-1.
36. Forster S, Liu X, Adam U, Schareck WD, Hopt UT. Islet autotransplantation combined with pancreatectomy for treatment of pancreatic adenocarcinoma: a case report. Transplant Proc. 2004;36: 1125-6.
37. Toso C, Oberholzer J, Ris F. Factors affecting human islet of Langerhans isolation yields. Transplant Proc. 2002;34:826.
38. Sabek O, Hathaway D, Fraga D, Gabor AO. Influence of Human Donor Factors on Pancreatic Collagenase Digestion. Transplant Proc. 1998;30:353.
39. Grupo de Trabajo para el trasplante de páncreas e islotes. Documento de consenso sobre tasplante de páncreas e islotes. Rev Esp Trasp. 2005;14:207-41.
40. O'Gorman D, Tatsuya K, Murdoch T, Richer B, McGhee-Wilson D, Ryan E, et al. The standarization of pancreatic donors for islet isolations. Transplantation. 2005;80:801-6.
41. Matsumoto I, Sawada T, Nakano M. Improvement in islet yield from obese donors for human islets transplants. Transplantation. 2004;78:880.
42. Lakey J, Warnock G, Rajotte R, et al. Factors in cadaveric donors that affect recovery of human islets of Langerhans. Transplat Proc. 1995;27:3265.
43. Deai T, Tanioka Y, Suzuki Y, Kuroda Y. The effect of the two-layer cold storage method on islet isolation from ischemically damaged pancreas. Kobe J Med Sci. 1999;45:191-9.
44. Tanioka Y, Sutherland DE, Kuroda Y, Gilmore TR, Asaheim TC, Kronson JW, et al. Excellence of the two-layer method (University of Wisconsin solution/perfluorochemical) in pancreas preservation before islet isolation. Surgery. 1997;122:435-41.
45. Tanioka Y, Sutherland DE, Kuroda Y, Suzuki Y, Matsumoto I, Deai T. Preservation of dog pancreas before islet isolation with the two-layer method. Transplant Proc. 1998;30:3419-20.
46. Matsumoto S. Clinical application of perfluorocarbons for organ preservation. Artif Cells Blood Substit Immobil Biotechnol. 2005; 33:75-82.
47. Tsujimura T, Kuroda Y, Avila JG, Kin T, Oberholzer J, Shapiro AM, et al. Influence of pancreas preservation on human islet isolation outcomes: impact of the two-layer method. Transplantation. 2004; 15;78:96-100.
48. Saito T, Ise K, Sato Y, Gotoh M, Matsumoto S, Kenmochi T, et al. The start of an islet transplantation program in Japan. Transplant Proc. 2005;37:3424-6.
49. Tanaka T, Suzuki Y, Tanioka Y, Sakai T, Kakinoki K, Goto T, et al. Possibility of islet transplantation from a nonheartbeating donor pancreas resuscitated by the two-layer method. Transplantation. 2005;27;80:738-42.
50. Kakinoki K, Fujino Y, Suzuki Y, Li S, Tanioka Y, Sakai T, et al. Superiority of the two-layer method before islet isolation confirmed by in vivo viability assessment. Transplantation. 2005;79:1516-21.
51. Matsumoto S, Zhang G, Qualley S, Clever J, Tombrello Y, Strong DM, et al. The effect of two-layer (University of Wisconsin solution/ perfluorochemical) preservation method on clinical grade pancreata prior to islet isolation and transplantation. Transplant Proc. 2004;36: 1037-9.
52. Tsujimura T, Kuroda Y, Churchill TA, Avila JG, Kin T, Shapiro AM, et al. Short-term storage of the ischemically damaged human pancreas by the two-layer method prior to islet isolation. Cell Transplant. 2004;13:67-73.
53. 2) method of pancreas preservation on human islet isolation, as assessed by the Edmonton Isolation Protocol. Transplantation. 2002;74:1414-9.
54. Langer RM, Mathe Z, Doros A, Mathe ZS, Weszelits V, Filo A, et al. Successful islet after kidney transplantations in a distance over 1000 kilometres: Preliminary results of the Budapest-Geneva collaboration. Transplant Proc. 2004;36:3113-5.
55. Ricordi C, Fraker C, Szust J, Al-Abdullah I, Poggioli R, Kirlew T, et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation. 2003;75:1524-7.
56. Noguchi H, Nakai Y, Matsumoto S, Kawaguchi M, Ueda M, Okitsu T, et al. Cell permeable peptide of JNK inhibitor prevents islet apoptosis immediately after isolation and improves islet graft function. Am J Transplant. 2005;5:1848-55.
57. Brandhorst D, Iken M, Brendel MD, Bretzel RG, Brandhorst H. Long-term preservation of the pig pancreas by a one-layer method for successful islet isolation. Transplant Proc. 2005;37:229-30.
58. Brandhorst D, Iken M, Brendel MD, Bretzel FIG, Brandhorst H. Successful pancreas preservation by a perfluorocarbon-based one-layer method for subsequent pig islet isolation. Transplantation. 2005;79:433-7.
59. Matsumoto S, Iwanaga Y, Okitsu T, Noguchi H, Yonekawa Y, Tanaka K, et al. Analysis of large-scale nonhuman primate islet isolations. Transplant Proc. 2005;37:1317-21.
60. Matsumoto S, Rigley TH, Reems JA, Kuroda Y, Stevens RB. Improved islet yields from Macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition. Am J Transplant. 2003;3:53-63.
61. Barnett MJ, Zhai X, LeGatt DF, Cheng SB, Shapiro AM, Lakey JR. Quantitative assessment of collagenase blends for human islet isolation. Transplantation. 2005;80:723-8.
62. Balamurugan AN, He J, Guo F, S Stolz DB, Bertera S, Geng X, et al. Harmful delayed effects of exogenous isolation enzymes on isolated human islets: relevance to clinical transplantation. Am J Transplant. 2005;5:2671-81.
63. Balamurugan AN, Chang Y, Fung JJ, Trucco M, Bottino R. Flexible management of enzymatic digestion improves human islet isolation outcome from sub-optimal donor pancreata. Am J Transplant. 2003;3:1135-42.
64. Bonner-Weir S, Toschi E, Inada A, et al. The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatr Diabetes. 2004;5 Suppl 2:16-22.
65. Ogata T, Park KY, Seno M, Kojima I. Reversal of streptozotocin-induced hyperglycemia by transplantation of pseudoislets consisting of beta cells derived from ductal cells. Endocr J. 2004;51:381-6.
66. Bogdani M, Lefebvre V, Buelens N, Bock T, Pipeleers-Marichal M, et al. Formation of insulin-positive cells in implants of human pancreatic duct cell preparations from young donors. Diabetologia. 2003;46:830-8.
67. Ichii H, Wang X, Álvarez A, Baidal D, Khan A, Pileggi A, et al. Pre-transplant assessment of fractional Beta cell viability correlates with clinical islet transplantation outcomes. Transplantation. 2006; 82 Suppl 2:341-2.
68. Goto M, Holgersson J, Kumagai-Braesch M, Korsgren O. The ADP/ATP Ratio: A novel predictive assay for quality assessment of isolated pancreatic islets. Am J Transplant. 2006;6:2483-7.
69. Barnett MJ, McGhee-Wilson D, Shapiro AM, Lakey JR. Variation in human islet viability based on different membrane integrity stains. Cell Transplant. 2004;13:481-8.
70. Ichii H, Inverardi L, Pileggi A, Molano RD, Cabrera O, Caicedo A, et al. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant. 2005;5:1635-45.
71. Marzorati S, Antonioli B, Nano R, Maffi P, Piemonti L, Giliola C, et al. Culture medium modulates proinflammatory conditions of human pancreatic islets before transplantation. Am J Transplant. 2006 [en prensa].
72. Olsson R, Maxhuni A, Carlsson PO. Revascularization of transplanted pancreatic islets following culture with stimulators of angiogenesis. Transplantation. 2006;82:340-7.
73. Vara E, Arias-Diaz J, Garcia C, Balibrea JL. Influence of cryopreservation on the sensitivity of human islets to tumor necrosis factor. Pancreas. 1996;13:29-37.
74. Von Mach MA, Schlosser J, Weiland M, Feilen PJ, Ringel M, Hengstler JG, et al. Size of pancreatic islets of Langerhans: a key parameter for viability after cryopreservation. Acta Diabetol. 2003; 40:123-9.
75. Cui YF, Ma M, Wang ZD, Zhang L, Hu ZL, Han DE. Prevention of central cell damage to isolated islets of Langerhans in hamsters by low temperature preconditioning. Hepatobiliary Pancreat Dis Int. 2005;4:139-43.
76. Omori K, Valiente L, Orr C, Rawson J, Ferreri K, Todorov I, et al. Inhibition of p38 mitogen-activated protein kinase protects human islets from cryoinjury and improves the yield, viability, and quality of frozen-thawed islets. Transplant Proc. 2005;37:3422-3.
77. Gatto C, Callegari M, Folin M, Conconi M, Paolin A, Di Falco G, et al. Effects of cryopreservation and coculture with pancreatic ductal epithelial cells on insulin secretion from human pancreatic islets. Int J Mol Med. 2003;12:851-4.
78. Matsumoto S, Matsusita M, Morita T, Kamachi H, Tsukiyama S, Furukawa Y, et al. Effects of synthetic antifreeze glycoprotein analogue on islet cell survival and function during cryopreservation. Cryobiology. 2006;52:90-8.
79. Bucher P, Mathe Z, Bosco D, Becker C, Kessler L, Greget M. et al. Morbidity associated with intraportal islet transplantation. Transplant Proc. 2004;36:1119-20.
80. Venturini M, Angeli E, Maffi P, Fiorina P, Bertuzzi F, Salvioni M, et al. Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US. Radiology. 2005;234:617-24.
81. Ryan EA, Paty BW, Senior PA, Shapiro AM. Risks and side effects of islet transplantation. Curr Diab Rep. 2004;4:304-9.
82. Brennan DC, Shannon MB, Koch MJ, Polonsky KS, Desai N, Shapiro J. Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation. Transplantation. 2004; 15;78:172-3.
83. Barshes NR, Lee TC, Goodpastor SE, et al. Transaminitis after pancreatic islet transplantation. J Am Coll Surg. 2005;200:353-61.
84. Hafiz MM, Faradji RN, Froud T, Pileggi A, Baidal DA, Cure P, et al. Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation. Transplantation. 2005;80:1718-28.
85. Paty BW, Ryan EA, Shapiro AM, Lakey JR, Robertson RP. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes. 2002;51:3428-34.
86. Kendall DM, Teuscher AU, Robertson RP. Defective glucagon secretion during sustained hypoglycemia following successful islet allo-and autotransplantation in humans. Diabetes. 1997;46:23-7.
87. Gupta V, Wahoff DC, Rooney DP, et al. The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes. 1997: 46:28-33.
88. Pyzdrowski KL, Kendall DM, Halter JB, Nakhleh RE, Sutherland DER, Robertson RP. Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med. 1992;327: 220-6.
89. Griffith RC, Scharp DW, Hartman BK, Ballinger WF, Lacy PE. A morphologic study of intrahepatic portal-vein islet isografts. Diabetes. 1997;26:201-14.
90. Vajkoczy P, Menger MD, Simpson E, Messmer K. Angiogenesis and vascularization of murine pancreatic islet isografts. Transplantation. 1995;60:123-7.
91. Vasir B, Aiello LP, Yoon KH, Quickel RR, Bonner-Weir S, Weir GC. Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes. 1998;47:1894-903.
92. Carlsson PO, Palm F, Mattsson G. Low revascularization of experimentally transplanted human pancreatic islets. J Clin Endocrinol Metab. 2002;87:5418-23.
93. Hirshberg B, Mog S, Patterson N, Leconte J, Harlan DM. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using Edmonton protocol immunosuppression. J Clin Endocrinol Metab. 2002;87:5424-9.
94. Bonner-Weir S, Taneja M, Weir GC, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A. 2000;97:7999-8004.
95. Carlsson PO, Palm F, Andersson A, Liss P. Chronically decreased oxygen tension in rat pancreatic islets transplanted under the kidney capsule. Transplantation. 2000;69:761-6.
96. Hanahan DJ. Platelet activating factor: a biologically active phosphoglyceride. Annu Rev Biochem. 1986;55:483-509.
97. Carlsen E, Flatmark A, Prydz H. Cytokine-induced procoagulant activity in monocytes and endothelial cells. Further enhancement by cyclosporine. Transplantation. 1988;46:575-80.
98. Ogawa S, Gerlach H, Esposito C, Pasagian-Macaulay A, Brett J, Stern D. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J Clin Invest. 1990:85. 1090-8.
99. Nussler AK, Carroll PB, Di Silvio M, Rilo HL, Simmons RL, Starzl TE, et al. Hepatic nitric oxide generation as a putative mechanism for failure of intrahepatic islet cell grafts. Transplant Proc. 1992;24:2997.
100. Starzl TE, Francavilla A, Halgrimson CG, Francavilla FR, Porter KA, Brown TH, et al. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet. 1973;137:179-99.
101. Hirshberg B, Mog S, Patterson N, Leconte J, Harlan DM. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using Edmonton protocol immunosuppression. J Clin Endocrinol Metab. 2002;87:5424-9.
102. Sutherland DER, Sibley R, Xu XZ, et al. Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type 1 diabetes. Transplant Assoc Am Physicians. 1984;97:80-7.
103. Wahoff DC, Papalois BE, Najarian JS, et al. Autologus islet transplantation to prevent diabetes after pancreatic resection. Ann Surg. 1995;222:562-79.
104. Barshes NR, Lee T, Goodpasture S, Brunicardi FC, Alejandro R, Ricordi C, et al. Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first year review. Transplant Proc. 2004;36:1127-9.
105. Kenmochi T, Mullen Y, Miyamoto M, Stein E. Protection of mouse islet isografts from early transplantation damage by nicotinamide treatment of recipients. Transplant Proc. 1994;26:693.
106. Bottino R, Fernandez LA, Ricordi C, Lehmann R, Tsan MF, Oliver R, et al. Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation, Diabetes. 1998;47:316-23.
107. Mandrup-Poulsen T, Spinas GA, Prowse SJ, Hansen BS, Jorgensen DW, Bendtzen K, et al. Islet cytotoxicity of interleukin 1. Influence of culture culture conditions or islet don characteristics. Diabetes. 1987;36:641-7.
108. Nagata M, Mullen Y, Matsuo S, Herrera M, Clare-Salzler M. Destruction of islet isografts by severe nonspecific inflammation. Transplant Proc. 1990;22:855-6.
109. Alejandro R, Cutfield RG, Shienvold FL, Polonsky, KS, Noel J, Olson L, et al. Natural history of intrahepatic canine islet cell autografts. J Clin Invest. 1986;78:1339-48.
110. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. Beta-cell death and mass in syngeneically transplanted islets exposed to short-and long-term hyperglycemia. Diabetes. 2002;51:66-72.
111. Eizirik DL, Mandrup-Poulsen T. A choice of death. The signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia. 2001;44:2115-33.
112. Saldeen J. Cytokines induce both necrosis and apoptosis via a common bcl2-inhibitable pathway in rat insulin producing cells. Endocrinology. 2000;141:2003-10.
113. Paraskevas S, Aikin R, Maysinger D, Lakey JRT, Cabanagh TJ, Agapitos D, et al. Modulation of JNK and p38 stress activated protein kinases in isolated islets of Langerhans. Insulin as an autocrine survival. Annals of Surgery 2001;233:124-33.
114. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene. 1999;18:6853-56.
115. Tak PP, Firestein GS. NF-kappaB: A key role in inflammatory diseases. J Clin Invest. 2001;107:7-11.
116. Zhang N, Su D, Qu S, Tse T, Bottino R, Balamurugan AN, et al. Sirolimus is associated with reduced islet engraftment and impaired beta-cell function. Diabetes 2006;55:2429-36.
117. Balibrea JM. Estudio del rechazo primario en el trasplante de islotes pancreáticos [tesis doctoral]. Madrid: Universidad Complutense; 2006.
118. Hering BJ, Kandaswarny R, Jeffrey D, et al. Single-donor, marginal-dose islet transplantation in patients with type-1 diabetes. JAMA. 2005;293:830-5.
119. Berney T, Bucher P, Kessler L, et al. Islet after kidney (IAK) transplantation in patients with type 1 diabetes using a novel immunosuppression protocol: preliminary results of the GRAGIL 1B multicenter trial. Transplantation. 2003;76 Suppl:S23.
120. Kenyon NS, Wijkstrom M, Kirchhof N, et al. Development of a non-human primate marginal mass model and preliminary demonstration of enhanced metabolic control in allogneic islet recipients treated with TP10 and immunosuppressed with basiliximab, RAD001 and FTY720. Am J Transp. 2002;Suppl 3:362.
121. Hering BJ, Kandaswamy R, Harmon JV, et al. Insulin independence after single-donor islet transplantation in type 1 diabetes with hOKT3-1 (ala-ala), sirolimus and tacrolimus therapy. Am J Transplant. 2001;Suppl 1:180.
122. Buhler L, Alwayn IP, Appel JZ III, et al. Anti-CD154 monoclonal antibody and thromboembolism. Transplantation. 2001;71:491.
123. Yang Z, Chen M, Ellett JD, Carter JD, Brayman KL, Nadler JL. Inflammatory blockade improves human pancreatic islet function and viability. Am J Transplant. 2005;5:475-83.
124. Nakano M, Matsumoto I, Sawada T, Ansite J, Oberbroeckling J, Zhang HJ, et al. Caspase-3 inhibitor prevents apoptosis of human islets immediately after isolation and improves islet graft function. Pancreas. 2004;29:104-9.
125. Brandhorst D, Kumarasamy V, Maatoui A, Alt A, Bretzel RG, Brandhorst H. Porcine islet graft function is affected by pretreatment with a caspase-3 inhibitor. Cell Transplant. 2006;15:311-7.
126. Ricordi C, Inveradi L, Kenyon NS, Goss J, Bertuzzi F, Alejandro R. Requirements for success in clinical islet transplantation. Transplantation. 2005;79:1298-300.
127. Shapiro AM, Ricordi C. Unraveling the secrets of single donor success in islet transplantation. Am J Transplant. 2004;4:295.